#METABOLOMICS WORKBENCH rcswasti_20250109_214156 DATATRACK_ID:5518 STUDY_ID:ST003660 ANALYSIS_ID:AN006011 PROJECT_ID:PR002270
VERSION             	1
CREATED_ON             	January 14, 2025, 8:45 am
#PROJECT
PR:PROJECT_TITLE                 	Kingdom-specific lipid unsaturation calibrates sequence evolution in membrane
PR:PROJECT_TITLE                 	arm subunits of eukaryotic respiratory complexes
PR:PROJECT_SUMMARY               	Sequence evolution of protein complexes (PCs) is constrained by protein-protein
PR:PROJECT_SUMMARY               	interactions (PPIs). PPI-interfaces are predominantly conserved and hotspots for
PR:PROJECT_SUMMARY               	disease-related mutations. How do lipid-protein interactions (LPIs) constrain
PR:PROJECT_SUMMARY               	sequence evolution of membrane-PCs? We explore Respiratory Complexes (RCs) as a
PR:PROJECT_SUMMARY               	case study as these allow to compare sequence evolution in subunits exposed to
PR:PROJECT_SUMMARY               	both lipids in inner-mitochondrial membrane (IMM) and lipid-free aqueous matrix.
PR:PROJECT_SUMMARY               	We find that lipid-exposed surfaces of the IMM-subunits but not of the matrix
PR:PROJECT_SUMMARY               	subunits are populated with non-PPI disease-causing mutations signifying LPIs in
PR:PROJECT_SUMMARY               	stabilizing RCs. Further, IMM-subunits including their exposed surfaces show
PR:PROJECT_SUMMARY               	high intra-kingdom sequence conservation but remarkably diverge beyond.
PR:PROJECT_SUMMARY               	Molecular Dynamics simulation suggests contrasting LPIs of structurally
PR:PROJECT_SUMMARY               	superimposable but sequence-wise diverged IMM-exposed helices of Complex I (CI)
PR:PROJECT_SUMMARY               	subunit Ndufa1 from human and Arabidopsis depending on kingdom-specific
PR:PROJECT_SUMMARY               	unsaturation of cardiolipin fatty acyl chains. in cellulo assays consolidate
PR:PROJECT_SUMMARY               	inter-kingdom incompatibility of Ndufa1-helices due to the lipid-exposed amino
PR:PROJECT_SUMMARY               	acids. Plant-specific unsaturated fatty acids in human cells also trigger
PR:PROJECT_SUMMARY               	CI-instability. Taken together, we posit that altered LPIs calibrate sequence
PR:PROJECT_SUMMARY               	evolution at the IMM-arms of eukaryotic RCs.
PR:INSTITUTE                     	CSIR-Centre for Cellular & Molecular Biology
PR:LAST_NAME                     	Raychaudhuri
PR:FIRST_NAME                    	Swasti
PR:ADDRESS                       	Habsiguda, Uppal Road, Hyderabad, 500007, Telangana, India
PR:EMAIL                         	rcswasti@ccmb.res.in
PR:PHONE                         	+91914027192558
#STUDY
ST:STUDY_TITLE                   	Kingdom-specific lipid unsaturation calibrates sequence evolution in membrane
ST:STUDY_TITLE                   	arm subunits of eukaryotic respiratory complexes
ST:STUDY_SUMMARY                 	Sequence evolution of protein complexes (PCs) is constrained by protein-protein
ST:STUDY_SUMMARY                 	interactions (PPIs). PPI-interfaces are predominantly conserved and hotspots for
ST:STUDY_SUMMARY                 	disease-related mutations. How do lipid-protein interactions (LPIs) constrain
ST:STUDY_SUMMARY                 	sequence evolution of membrane-PCs? We explore Respiratory Complexes (RCs) as a
ST:STUDY_SUMMARY                 	case study as these allow to compare sequence evolution in subunits exposed to
ST:STUDY_SUMMARY                 	both lipids in inner-mitochondrial membrane (IMM) and lipid-free aqueous matrix.
ST:STUDY_SUMMARY                 	We find that lipid-exposed surfaces of the IMM-subunits but not of the matrix
ST:STUDY_SUMMARY                 	subunits are populated with non-PPI disease-causing mutations signifying LPIs in
ST:STUDY_SUMMARY                 	stabilizing RCs. Further, IMM-subunits including their exposed surfaces show
ST:STUDY_SUMMARY                 	high intra-kingdom sequence conservation but remarkably diverge beyond.
ST:STUDY_SUMMARY                 	Molecular Dynamics simulation suggests contrasting LPIs of structurally
ST:STUDY_SUMMARY                 	superimposable but sequence-wise diverged IMM-exposed helices of Complex I (CI)
ST:STUDY_SUMMARY                 	subunit Ndufa1 from human and Arabidopsis depending on kingdom-specific
ST:STUDY_SUMMARY                 	unsaturation of cardiolipin fatty acyl chains. in cellulo assays consolidate
ST:STUDY_SUMMARY                 	inter-kingdom incompatibility of Ndufa1-helices due to the lipid-exposed amino
ST:STUDY_SUMMARY                 	acids. Plant-specific unsaturated fatty acids in human cells also trigger
ST:STUDY_SUMMARY                 	CI-instability. Taken together, we posit that altered LPIs calibrate sequence
ST:STUDY_SUMMARY                 	evolution at the IMM-arms of eukaryotic RCs.
ST:INSTITUTE                     	CSIR-Centre for Cellular & Molecular Biology
ST:LAST_NAME                     	Raychaudhuri
ST:FIRST_NAME                    	Swasti
ST:ADDRESS                       	Habsiguda, Uppal Road, Hyderabad, 500007, Telangana, India
ST:EMAIL                         	rcswasti@ccmb.res.in
ST:PHONE                         	+914027192558
#SUBJECT
SU:SUBJECT_TYPE                  	Cultured cells
SU:SUBJECT_SPECIES               	Homo sapiens
SU:TAXONOMY_ID                   	9606
SU:CELL_BIOSOURCE_OR_SUPPLIER    	ATCC
SU:CELL_STRAIN_DETAILS           	HEK293T
#FACTORS
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	-	HEK293T-BSA-R1	Treatment:Control | Sample source:HEK293T cultured cells	RAW_FILE_NAME(Raw data file name)=HEK-BSA-R1.wiff
SUBJECT_SAMPLE_FACTORS           	-	HEK293T-BSA-R2	Treatment:Control | Sample source:HEK293T cultured cells	RAW_FILE_NAME(Raw data file name)=HEK-BSA-R2.wiff
SUBJECT_SAMPLE_FACTORS           	-	HEK293T-BSA-R3	Treatment:Control | Sample source:HEK293T cultured cells	RAW_FILE_NAME(Raw data file name)=HEK-BSA-R3.wiff
SUBJECT_SAMPLE_FACTORS           	-	HEK293T-BSA-R4	Treatment:Control | Sample source:HEK293T cultured cells	RAW_FILE_NAME(Raw data file name)=HEK-BSA-R4.wiff
SUBJECT_SAMPLE_FACTORS           	-	HEK293T-BSA-R5	Treatment:Control | Sample source:HEK293T cultured cells	RAW_FILE_NAME(Raw data file name)=HEK-BSA-R5.wiff
SUBJECT_SAMPLE_FACTORS           	-	HEK293T-BSA-R6	Treatment:Control | Sample source:HEK293T cultured cells	RAW_FILE_NAME(Raw data file name)=HEK-BSA-R6.wiff
SUBJECT_SAMPLE_FACTORS           	-	HEK293T-18 2-treated-R1	Treatment:Linoleic acid treatment | Sample source:HEK293T cultured cells	RAW_FILE_NAME(Raw data file name)=HEK-18-2-R1.wiff
SUBJECT_SAMPLE_FACTORS           	-	HEK293T-18 2-treated-R2	Treatment:Linoleic acid treatment | Sample source:HEK293T cultured cells	RAW_FILE_NAME(Raw data file name)=HEK-18-2-R2.wiff
SUBJECT_SAMPLE_FACTORS           	-	HEK293T-18 2-treated-R3	Treatment:Linoleic acid treatment | Sample source:HEK293T cultured cells	RAW_FILE_NAME(Raw data file name)=HEK-18-2-R3.wiff
SUBJECT_SAMPLE_FACTORS           	-	HEK293T-18 2-treated-R4	Treatment:Linoleic acid treatment | Sample source:HEK293T cultured cells	RAW_FILE_NAME(Raw data file name)=HEK-18-2-R4.wiff
SUBJECT_SAMPLE_FACTORS           	-	HEK293T-18 2-treated-R5	Treatment:Linoleic acid treatment | Sample source:HEK293T cultured cells	RAW_FILE_NAME(Raw data file name)=HEK-18-2-R5.wiff
SUBJECT_SAMPLE_FACTORS           	-	HEK293T-18 2-treated-R6	Treatment:Linoleic acid treatment | Sample source:HEK293T cultured cells	RAW_FILE_NAME(Raw data file name)=HEK-18-2-R6.wiff
SUBJECT_SAMPLE_FACTORS           	-	HEK293T-18 3-treated-R1	Treatment:Linolenic acid treatment | Sample source:HEK293T cultured cells	RAW_FILE_NAME(Raw data file name)=HEK-18-3-R1.wiff
SUBJECT_SAMPLE_FACTORS           	-	HEK293T-18 3-treated-R2	Treatment:Linolenic acid treatment | Sample source:HEK293T cultured cells	RAW_FILE_NAME(Raw data file name)=HEK-18-3-R2.wiff
SUBJECT_SAMPLE_FACTORS           	-	HEK293T-18 3-treated-R3	Treatment:Linolenic acid treatment | Sample source:HEK293T cultured cells	RAW_FILE_NAME(Raw data file name)=HEK-18-3-R3.wiff
SUBJECT_SAMPLE_FACTORS           	-	HEK293T-18 3-treated-R4	Treatment:Linolenic acid treatment | Sample source:HEK293T cultured cells	RAW_FILE_NAME(Raw data file name)=HEK-18-3-R4.wiff
SUBJECT_SAMPLE_FACTORS           	-	HEK293T-18 3-treated-R5	Treatment:Linolenic acid treatment | Sample source:HEK293T cultured cells	RAW_FILE_NAME(Raw data file name)=HEK-18-3-R5.wiff
SUBJECT_SAMPLE_FACTORS           	-	HEK293T-18 3-treated-R6	Treatment:Linolenic acid treatment | Sample source:HEK293T cultured cells	RAW_FILE_NAME(Raw data file name)=HEK-18-3-R6.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-1	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-1.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-2	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-2.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-3	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-3.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-4	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-4.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-5	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-5.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-6	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-6.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-7	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-7.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-8	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-8.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-9	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-9.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-10	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-10.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-11	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-11.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-12	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-12.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-13	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-13.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-14	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-14.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-15	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-15.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-16	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-16.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-17	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-17.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-18	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-18.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-19	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-19.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-20	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-20.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-21	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-21.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-22	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-22.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-23	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-23.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-24	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-24.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-25	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-25.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-26	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-26.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-27	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-27.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-28	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-28.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-29	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-29.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-30	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-30.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-31	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-31.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-32	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-32.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-33	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-33.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-34	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-34.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-35	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-35.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-36	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-36.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-37	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-37.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-38	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-38.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-39	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-39.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-40	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-40.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-41	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-41.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-42	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-42.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-43	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-43.wiff
SUBJECT_SAMPLE_FACTORS           	-	Experimental Blank-44	Treatment:Blank | Sample source:LC buffer	RAW_FILE_NAME(Raw data file name)=Blank-44.wiff
#COLLECTION
CO:COLLECTION_SUMMARY            	HEK293T cells (Human Embryonic Kidney) were treated with BSA-conjugated linoleic
CO:COLLECTION_SUMMARY            	acid and linolenic acid and incubated at 37°C for 72 hours in a CO2 incubator.
CO:COLLECTION_SUMMARY            	Cells were trypsinized and pelleted, and mitochondria were isolated and stored
CO:COLLECTION_SUMMARY            	at -80°C. Lipids were isolated, dried in a stream of nitrogen, and further
CO:COLLECTION_SUMMARY            	stored at -80°C until further use
CO:SAMPLE_TYPE                   	Cultured cells
CO:STORAGE_CONDITIONS            	-80℃
#TREATMENT
TR:TREATMENT_SUMMARY             	Hs-A1-EGFP expressing HEK293T cells were treated with BSA-conjugated linoleic
TR:TREATMENT_SUMMARY             	acid and linolenic acid as described by Omer et al (Oemer G, et al. The lipid
TR:TREATMENT_SUMMARY             	environment modulates cardiolipin and phospholipid constitution in wild type and
TR:TREATMENT_SUMMARY             	tafazzin-deficient cells. J Inherit Metab Dis 45, 38-50 (2022). PMID: 34494285)
TR:TREATMENT_SUMMARY             	with slight modifications. Briefly, 10 mM solutions of fatty acids (Sigma) were
TR:TREATMENT_SUMMARY             	prepared by dissolving in absolute ethanol. Meanwhile, 10% fatty acid-free BSA
TR:TREATMENT_SUMMARY             	(Sigma) was prepared in 1X PBS (pH 7.4) and incubated at 55°C for 30 minutes
TR:TREATMENT_SUMMARY             	with intermittent vortexing. The solution was cooled to 25°C and filter
TR:TREATMENT_SUMMARY             	sterilized. The 10 mM fatty acid solution was diluted 1:20 in 10% BSA (final
TR:TREATMENT_SUMMARY             	fatty acid concentration: 500 μM) and incubated at 55°C for 30 mins with
TR:TREATMENT_SUMMARY             	intermittent vortexing. The BSA-conjugated fatty acid stock solution was further
TR:TREATMENT_SUMMARY             	diluted 1:10 in incomplete DMEM (final concentration: 50 μM of fatty acid in 1%
TR:TREATMENT_SUMMARY             	BSA) and supplemented to cells. Control cells were supplemented with
TR:TREATMENT_SUMMARY             	BSA-conjugated ethanol. The cells were induced with 1mg/ml doxycycline and
TR:TREATMENT_SUMMARY             	incubated at 37°C and 5 % CO2 for 72 hours. Prior to lipid supplementation,
TR:TREATMENT_SUMMARY             	cells were plated in DMEM and 10% FBS and allowed to adhere for at least 16
TR:TREATMENT_SUMMARY             	hours. Cells were pelleted after 72 hours of treatment and mitochondria-enriched
TR:TREATMENT_SUMMARY             	fraction preparation was performed according to Rawat et al. (Rawat S, Ghosh S,
TR:TREATMENT_SUMMARY             	Mondal D, Anusha V, Raychaudhuri S. Increased supraorganization of respiratory
TR:TREATMENT_SUMMARY             	complexes is a dynamic multistep remodelling in response to proteostasis stress.
TR:TREATMENT_SUMMARY             	J Cell Sci 133, (2020). PMID: 32878939) with slight modification. Briefly, ∼20
TR:TREATMENT_SUMMARY             	million cells were homogenized at 4°C in a Dounce homogenizer with 600 ml of
TR:TREATMENT_SUMMARY             	buffer A (83 mM sucrose, 10 mM MOPS pH 7.2). After adding an equal volume of
TR:TREATMENT_SUMMARY             	buffer B (250 mM sucrose, 30 mM MOPS pH 7.2), nuclei and unbroken cells were
TR:TREATMENT_SUMMARY             	removed by centrifugation at 1000 g for 5 min at 4°C. The supernatant was
TR:TREATMENT_SUMMARY             	further centrifuged at 12,000 g for 5 min and washed twice with buffer C (320 mM
TR:TREATMENT_SUMMARY             	sucrose, 1 mM EDTA, 10 mM Tris-HCl pH 7.4). The pellet was resuspended in 1X
TR:TREATMENT_SUMMARY             	NativePAGE sample buffer (Invitrogen) to obtain a mitochondria-enriched fraction
TR:TREATMENT_SUMMARY             	followed by storing at -80°C until further use.
TR:TREATMENT                     	BSA conjugated fatty acids
TR:TREATMENT_COMPOUND            	Linoleic acid and Linolenic acid
TR:TREATMENT_ROUTE               	Adding to cell culture media
TR:TREATMENT_DOSE                	50 μM
TR:TREATMENT_DOSEDURATION        	72 hours
TR:TREATMENT_VEHICLE             	BSA
TR:CELL_GROWTH_CONTAINER         	CO2 incubator
TR:CELL_GROWTH_RATE              	Doubling time 16 hourse
TR:CELL_MEDIA                    	DMEM
TR:CELL_ENVIR_COND               	37°C, 5% CO2
TR:CELL_HARVESTING               	Trypnising and pelleting
TR:CELL_PCT_CONFLUENCE           	80%
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated
SP:SAMPLEPREP_SUMMARY            	Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by
SP:SAMPLEPREP_SUMMARY            	modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol
SP:SAMPLEPREP_SUMMARY            	(MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the
SP:SAMPLEPREP_SUMMARY            	mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by
SP:SAMPLEPREP_SUMMARY            	centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh
SP:SAMPLEPREP_SUMMARY            	glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl
SP:SAMPLEPREP_SUMMARY            	of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The
SP:SAMPLEPREP_SUMMARY            	organic phase was pooled and dried under the stream of nitrogen gas. Isolated
SP:SAMPLEPREP_SUMMARY            	mitochondria and dried lipids were stored in -80°C until further use.
SP:PROCESSING_STORAGE_CONDITIONS 	4℃
SP:EXTRACTION_METHOD             	Modified Folch Method
SP:EXTRACT_STORAGE               	-80℃
SP:SAMPLE_RESUSPENSION           	CHCL2:MEOH- 1:2
SP:SAMPLE_SPIKING                	CL 56:0, cardiolipin
SP:SUBCELLULAR_LOCATION          	Mitochondria
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_SUMMARY        	Dried lipids were resuspended in 60 μl of 2:1 (v/v) dichloromethane (CH2Cl2):
CH:CHROMATOGRAPHY_SUMMARY        	MeOH on the day of analysis. 25 μl of sample was analyzed using Shimadzu UHPLC
CH:CHROMATOGRAPHY_SUMMARY        	LC40D coupled with Sciex QTRAP 6500+ mass spectrometer. Lipid extracts were
CH:CHROMATOGRAPHY_SUMMARY        	separated on C18 reverse phase column (Phenomenex Gemini, 5 μm, 50 x 4.6 mm)
CH:CHROMATOGRAPHY_SUMMARY        	using solvent A as 95:5 (v/v) H2O:MeOH + 0.1% Formic acid + 10mM ammonium
CH:CHROMATOGRAPHY_SUMMARY        	formate and solvent B as 60:35:5 (v/v/v) Isopropanol:MeOH:H2O + 0.1% Formic acid
CH:CHROMATOGRAPHY_SUMMARY        	+ 10mM ammonium formate. LC gradient was set for 65 min: 5% B for 5 min with
CH:CHROMATOGRAPHY_SUMMARY        	0.5ml/min flow, a linear gradient of B from 5-100% over 25 min with 0.3ml/min
CH:CHROMATOGRAPHY_SUMMARY        	flow, 100% B from 25-55 min with 0.3ml/min flow, 100% B from 55-60 min with
CH:CHROMATOGRAPHY_SUMMARY        	0.5ml/min flow and re-equilibration with 5% B for 5 min. The column was
CH:CHROMATOGRAPHY_SUMMARY        	maintained at 55°C.
CH:CHROMATOGRAPHY_TYPE           	Reversed phase
CH:INSTRUMENT_NAME               	Shimadzu UHPLC LC40D
CH:COLUMN_NAME                   	Phenomenex Gemini C18 (50 x 4.6mm,5um)
CH:SOLVENT_A                     	95% water/5% methanol; 0.1% Formic acid; 10mM ammonium formate
CH:SOLVENT_B                     	60% isopropanol/35% methanol/5% water; 0.1% Formic acid; 10mM ammonium formate
CH:FLOW_GRADIENT                 	5% B for 5 min with 0.5ml/min flow, linear gradient of B from 5-100% over 25 min
CH:FLOW_GRADIENT                 	with 0.3ml/min flow, 100% B from 25-55 min with 0.3ml/min flow, 100% B from
CH:FLOW_GRADIENT                 	55-60 min with 0.5ml/min flow and re-equilibration with 5% B for 5 min
CH:FLOW_RATE                     	0.3mL/min-0.5mL/min
CH:COLUMN_TEMPERATURE            	55
CH:INJECTION_TEMPERATURE         	4
CH:INTERNAL_STANDARD             	Cardiolipin 56:0
CH:SAMPLE_INJECTION              	25μl
CH:ANALYTICAL_TIME               	65 mins
CH:OVEN_TEMPERATURE              	55°C
CH:WASHING_BUFFER                	IsoP:MeOH:ACN:H2O- 1:1:1:1
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
AN:ANALYSIS_PROTOCOL_FILE        	MS_protocol.txt
AN:DATA_FORMAT                   	.wiff
#MS
MS:INSTRUMENT_NAME               	ABI Sciex 6500+ QTrap
MS:INSTRUMENT_TYPE               	Triple quadrupole
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	NEGATIVE
MS:MS_COMMENTS                   	Lipids were quantified using the scheduled multiple reaction monitoring (MRM)
MS:MS_COMMENTS                   	method in Sciex QTRAP 6500+ in high mass and negative ion mode using
MS:MS_COMMENTS                   	collision-induced dissociation (CID). 96 transitions from 45 CL species
MS:MS_COMMENTS                   	including internal standard (IS) were monitored. Source and gas settings:
MS:MS_COMMENTS                   	curtain gas pressure 35 A.U.; Collision Gas (CAD) High; Ionspray Voltage -4500V;
MS:MS_COMMENTS                   	temperature 550 °C; Ion source gas 1&2 55; declustering potential -80V;
MS:MS_COMMENTS                   	collision energy -120V; entrance potential -10V; exit potential -13V; MRM
MS:MS_COMMENTS                   	detection window of 45s for IS and 180s for other CLs; minimum dwell time 100ms.
MS:MS_COMMENTS                   	Multiple blanks were run between samples. The area under curve (AUC) was
MS:MS_COMMENTS                   	calculated using Sciex OS, Analytics version 3.3.1.43 software with a minimum
MS:MS_COMMENTS                   	peak width of 7 points while the rest of the parameters were default. A minimum
MS:MS_COMMENTS                   	of 3 transitions per CL species were monitored (Table 1, MS_protocol.txt) where
MS:MS_COMMENTS                   	one transition – -152.9 corresponded to the head group (Glycerolphosphate-H2O)
MS:MS_COMMENTS                   	and the other two transitions belonged to fatty acid chains. -152.9 was defined
MS:MS_COMMENTS                   	as a qualifier. CL species lacking qualifier peaks were not considered for
MS:MS_COMMENTS                   	analysis. Further, 2 transitions of fatty acids were considered as quantifiers,
MS:MS_COMMENTS                   	and CL species where both the transitions were identified and had AUC greater
MS:MS_COMMENTS                   	than or equal to the order of qualifier were only considered for analysis. Each
MS:MS_COMMENTS                   	spectra was subtracted with its respective blank. The AUC of each CL species was
MS:MS_COMMENTS                   	normalized and % Abundance was calculated using the formula provided in
MS:MS_COMMENTS                   	MS_protocol.txt
MS:CAPILLARY_TEMPERATURE         	550 °C
MS:COLLISION_ENERGY              	-120V
MS:COLLISION_GAS                 	High
MS:FRAGMENTATION_METHOD          	CID
MS:ION_SOURCE_TEMPERATURE        	55
MS:ION_SPRAY_VOLTAGE             	-4500V
MS:MASS_ACCURACY                 	0.5Da
MS:PRECURSOR_TYPE                	[M-H]-
#MS_METABOLITE_DATA
MS_METABOLITE_DATA:UNITS	Blank substracted Area under curve
MS_METABOLITE_DATA_START
Samples	HEK293T-BSA-R1	HEK293T-BSA-R2	HEK293T-BSA-R3	HEK293T-BSA-R4	HEK293T-BSA-R5	HEK293T-BSA-R6	HEK293T-18 2-treated-R1	HEK293T-18 2-treated-R2	HEK293T-18 2-treated-R3	HEK293T-18 2-treated-R4	HEK293T-18 2-treated-R5	HEK293T-18 2-treated-R6	HEK293T-18 3-treated-R1	HEK293T-18 3-treated-R2	HEK293T-18 3-treated-R3	HEK293T-18 3-treated-R4	HEK293T-18 3-treated-R5	HEK293T-18 3-treated-R6
Factors	Treatment:Control | Sample source:HEK293T cultured cells	Treatment:Control | Sample source:HEK293T cultured cells	Treatment:Control | Sample source:HEK293T cultured cells	Treatment:Control | Sample source:HEK293T cultured cells	Treatment:Control | Sample source:HEK293T cultured cells	Treatment:Control | Sample source:HEK293T cultured cells	Treatment:Linoleic acid treatment | Sample source:HEK293T cultured cells	Treatment:Linoleic acid treatment | Sample source:HEK293T cultured cells	Treatment:Linoleic acid treatment | Sample source:HEK293T cultured cells	Treatment:Linoleic acid treatment | Sample source:HEK293T cultured cells	Treatment:Linoleic acid treatment | Sample source:HEK293T cultured cells	Treatment:Linoleic acid treatment | Sample source:HEK293T cultured cells	Treatment:Linolenic acid treatment | Sample source:HEK293T cultured cells	Treatment:Linolenic acid treatment | Sample source:HEK293T cultured cells	Treatment:Linolenic acid treatment | Sample source:HEK293T cultured cells	Treatment:Linolenic acid treatment | Sample source:HEK293T cultured cells	Treatment:Linolenic acid treatment | Sample source:HEK293T cultured cells	Treatment:Linolenic acid treatment | Sample source:HEK293T cultured cells
CL 16:1_16:1_16:1_16:1	184200	119200	177300	174000	48200	107700	2542	14250	12675	8055	3204	3102	13300	84240	23970	6615	9255	21880
CL 16:0_16:0_16:0_18:1	396	416794	0	0	55750	59300	71940	-10110	2210	0	30490	4698	2372	2418	0	0	861	27650
CL 16:0_16:1_16:1_18:2	46310	30270	31220	31990	20200	32540	2187	10950	5685	13390	11940	2705	8282	19580	8285	2457	7045	5228
CL 16:1_16:1_18:2_16:1	59830	75060	51460	53980	36460	39920	7515	28090	36310	17740	21300	4282	13490	37170	10850	2933	0	11740
CL 16:0_16:1_16:1_18:3	0	0	0	0	0	0	0	0	0	0	0	0	1520	25610	14010	0	0	4166
CL 16:0_16:0_18:1_18:1/ CL 16:0_16:1_18:0_18:1	-5827	-4306	5801	5812	341700	511000	13354	-16820	0	0	1131	-3848	-5364	-3336	0	0	172	-2348
CL 16:1_16:1_18:1_18:1	19610	12700	8003	-2169	0	25290	1704	3544	3848	6527	8810	0	0	0	291	0	3903	0
CL 16:0_16:0_18:1_18:3	0	0	0	3186	0	0	0	0	0	0	1135	0	1548	11340	0	0	0	0
CL 16:1_16:1_18:1_18:2/ CL 16:0_16:1_18:2_18:2	308700	248500	178300	230900	181600	178300	52250	75430	125678	83324	82910	20970	35210	158400	28080	15180	0	48210
CL 16:0_16:0_18:2_18:3/ CL 16:0_16:1_18:1_18:3/ CL 16:1_16:1_18:0_18:3	0	0	6549	7131	0	4633	4348	8415	10360	10910	0	0	12020	62040	26550	6253	13740	30500
CL 16:1_16:1_18:2_18:2	66650	102700	43500	46450	53540	67830	58730	159800	178800	107100	154100	23580	33250	61690	16990	9630	30840	41100
CL 16:1_16:1_18:1_18:3/ CL 16:0_16:1_18:2_18:3	4384	0	3061	0	0	0	0	0	0	0	0	0	44170	167300	63530	30960	64590	62970
CL 16:0_16:1_16:1_20:5	0	0	0	0	0	0	0	0	0	0	0	0	33500	114700	53010	13480	56960	55650
CL 16:1_16:1_18:2_18:3/ CL 16:0_16:1_18:3_18:3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
CL 16:1_16:1_16:1_20:5	0	0	0	-954.6	0	0	0	0	0	0	0	0	37160	128900	82520	47430	66540	67900
CL 16:1_16:1_18:3_18:3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
CL 16:0_18:1_18:1_18:1/ CL 16:1_18:0_18:1_18:1	149800	5340	70590	99120	63360	64800	0	5356	-2662	687	6364	3731	0	47460	8345	5952	0	10730
CL 16:0_18:0_18:0_18:3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
CL 16:0_18:1_18:1_18:2	0	115000	0	0	6305	0	12060	19750	23900	0	0	6261	15080	4407	0	0	15320	2834
CL 16:1_18:0_18:0_18:3/ CL 16:0_18:0_18:1_18:3	0	0	0	0	0	0	0	0	0	0	0	0	2393	0	0	0	0	0
CL 16:1_18:1_18:1_18:2	453945	330200	191300	270356	290600	329300	33320	162500	89679	70508	93518	35180	7046	173700	30411	24480	5565	57250
CL 16:0_18:1_18:1_18:3/ CL 16:1_18:0_18:1_18:3	0	0	0	0	0	0	0	0	0	0	0	0	9817	14390	19300	2531	22550	22290
CL 16:1_18:1_18:2_18:2	201500	2683	109800	134500	250300	213600	258000	539000	496474	279900	473900	69930	0	181269	26555	25470	0	95140
CL 16:1_18:1_18:1_18:3/ CL 16:0_18:0_18:3_18:3	6451	3619	2661	3211	2756	3188	0	0	0	0	0	0	0	236500	64550	46530	8294	95430
CL 16:1_18:2_18:2_18:2	41140	86190	33100	29534	57110	59710	275600	623100	441100	326800	803400	63650	87750	235300	77084	44390	153300	126300
CL 16:1_18:1_18:2_18:3/ CL 16:1_18:0_18:3_18:3	0	0	0	0	0	0	0	0	0	0	0	0	67050	238400	91330	27250	154600	116100
CL 16:1_16:1_18:2_20:4	0	0	0	-2127	0	0	0	0	0	0	4357	0	96800	322000	158100	109700	370400	182300
CL 16:1_18:1_18:3_18:3	10900	0	3558	5592	0	0	0	0	7152	0	0	0	40080	70490	32740	22480	93810	48860
CL 16:1_16:1_18:2_20:5	0	0	0	0	0	0	0	0	0	0	0	0	67530	140100	51740	69040	255700	153100
CL 16:1_18:2_18:3_18:3	0	0	0	0	0	0	0	0	0	0	0	0	37280	72580	37460	29850	96980	66400
CL 16:1_18:3_18:3_18:3	0	0	0	0	0	0	0	0	0	0	2948	0	52190	131100	121200	107200	305400	160600
CL 18:1_18:1_18:1_18:1	167000	48950	53900	93180	86240	68460	6307	8482	3569	5880	4776	0	719.2	37920	6354	4978	324.6	9558
CL 18:1_18:1_18:1_18:2/ CL 18:0_18:1_18:2_18:2	121400	102600	43030	64450	125100	62440	19140	24580	20240	14130	31319	4777	4517	45450	9477	4271	7283	31540
CL 18:1_18:1_18:2_18:2	178200	278900	61060	96410	222800	191800	208300	246400	226614	162242	475487	54660	58170	98960	26154	9968	25250	49390
CL 18:1_18:1_18:1_18:3	0	0	0	0	0	0	0	0	0	0	0	0	4650	101800	17610	12650	16220	41360
CL 18:1_18:2_18:2_18:2	98615	137500	45260	45510	121800	113200	530800	171372.2	111600	466700	2344000	146200	-2595	204443	46340	33755	11015	143000
CL 18:1_18:1_18:2_18:3/ CL 18:0_18:1_18:3_18:3	0	0	0	0	1368	0	0	0	0	0	0	0	0	125000	27340	40230	0	35610
CL 18:2_18:2_18:2_18:2	0	34480	12120	16570	54220	51970	566800	890200	851900	355700	2517000	123100	81726	132191	40290	29930	-3449	121200
CL 18:1_18:1_18:3_18:3	0	0	0	-3064	0	1299	0	0	0	0	6643	0	0	273600	100000	77900	0	163100
CL 16:0_18:2_18:2_20:5/ CL 16:1_18:1_18:2_20:5	0	0	0	0	0	0	2626	0	0	0	6647	0	108000	203600	114400	65810	562300	183200
CL 18:2_18:2_18:2_18:3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
CL 16:1_18:2_18:2_20:5	0	0	0	2809	0	0	0	0	0	0	11210	0	87200	169700	143100	141700	933500	282700
CL 18:2_18:2_18:3_18:3/ CL 18:1_18:3_18:3_18:3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
CL 18:2_18:3_18:3_18:3	0	0	0	0	0	0	0	0	0	0	0	0	33480	70410	81760	40480	472100	203600
CL 14:0_14:0_14:0_14:0	262642000	204600000	504272000	691230000	365868000	431065000	806134000	427337000	387360000	636057000	298372000	380702000	749753000	765870000	555140000	469130000	806208000	697538000
MS_METABOLITE_DATA_END
#METABOLITES
METABOLITES_START
metabolite_name	Pubchem Identifier	Retention time (min)	Quantified M/z (MS1)	Quantified M/z (MS2)
CL 16:1_16:1_16:1_16:1	131767780	35.4	1343.9	152.9, 253.2
CL 16:0_16:0_16:0_18:1	118701872	39.2	1377.9	152.9, 281.2, 255.2
CL 16:0_16:1_16:1_18:2	131766973	36.3	1371.9	152.9, 279.2, 253.2
CL 16:1_16:1_18:2_16:1	131767810	35.6	1369.9	152.9, 279.2, 253.2
CL 16:0_16:1_16:1_18:3	138284445	35.6	1369.9	152.9, 277.2, 253.2
CL 16:0_16:0_18:1_18:1/ CL 16:0_16:1_18:0_18:1	138125708/ 138179152	39.3	1403.9	152.9, 281.2, 255.2
CL 16:1_16:1_18:1_18:1	138272266	37	1399.9	152.9, 281.2, 253.2
CL 16:0_16:0_18:1_18:3	138292608	37	1399.9	152.9, 277.2, 281.2
CL 16:1_16:1_18:1_18:2/ CL 16:0_16:1_18:2_18:2	138195581/ 138148022	36.7	1397.9	152.9, 279.2, 253.2
CL 16:0_16:0_18:2_18:3/ CL 16:0_16:1_18:1_18:3/ CL 16:1_16:1_18:0_18:3	138127050/ 138230184/ 138205174	36.7	1397.9	152.9, 277.2, 253.2, 279.2
CL 16:1_16:1_18:2_18:2	138243780	36.1	1395.9	152.9, 279.2, 253.2
CL 16:1_16:1_18:1_18:3/ CL 16:0_16:1_18:2_18:3	138124283/ 138184666	36.1	1395.9	152.9, 277.2, 253.2, 279.2
CL 16:0_16:1_16:1_20:5	138260134	35.4	1393.9	152.9, 301.2, 253.2
CL 16:1_16:1_18:2_18:3/ CL 16:0_16:1_18:3_18:3	138204520/ 138223924	35.4	1393.9	152.9, 277.2, 253.2
CL 16:1_16:1_16:1_20:5	138121456	34.8	1391.9	152.9, 301.2, 253.2
CL 16:1_16:1_18:3_18:3	138138200	34.8	1391.9	152.9, 277.2, 253.2
CL 16:0_18:1_18:1_18:1/ CL 16:1_18:0_18:1_18:1	138189480/ 138181047	38.8	1430.1	152.9, 281.2, 255.2
CL 16:0_18:0_18:0_18:3	138262338	38.8	1430.1	152.9, 277.2, 255.2
CL 16:0_18:1_18:1_18:2	138120190	38.7	1427.9	152.9, 279.2, 281.2
CL 16:1_18:0_18:0_18:3/ CL 16:0_18:0_18:1_18:3	138289954/ 138256494	38.7	1427.9	152.9, 277.2, 281.2
CL 16:1_18:1_18:1_18:2	138255015	37.8	1425.9	152.9, 279.2, 281.2
CL 16:0_18:1_18:1_18:3/ CL 16:1_18:0_18:1_18:3	138191131/ 138305966	37.8	1425.9	152.9, 277.2, 281.2
CL 16:1_18:1_18:2_18:2	138209519	37	1423.9	152.9, 279.2, 281.2
CL 16:1_18:1_18:1_18:3/ CL 16:0_18:0_18:3_18:3	138236342/ 138311977	37	1423.9	152.9, 277.2, 281.2
CL 16:1_18:2_18:2_18:2	138126603	36.4	1421.9	152.9, 279.2, 253.2
CL 16:1_18:1_18:2_18:3/ CL 16:1_18:0_18:3_18:3	138223876/ 138225540	36.4	1421.9	152.9, 277.2, 253.2
CL 16:1_16:1_18:2_20:4	138184641	35.7	1419.9	152.9, 279.2, 253.2
CL 16:1_18:1_18:3_18:3	138261175	35.7	1419.9	152.9, 277.2, 253.2
CL 16:1_16:1_18:2_20:5	138205119	35.3	1417.9	152.9, 279.2, 253.2
CL 16:1_18:2_18:3_18:3	138156108	35.3	1417.9	152.9, 277.2, 253.2, 279.2
CL 16:1_18:3_18:3_18:3	138240999	34.6	1415.9	152.9, 277.2, 253.2
CL 18:1_18:1_18:1_18:1	10464221	40.3	1456.1	152.9, 281.2
CL 18:1_18:1_18:1_18:2/ CL 18:0_18:1_18:2_18:2	138173202/ 138283272	39.3	1454.1	152.9, 279.2, 281.2
CL 18:1_18:1_18:2_18:2	138243779	38.4	1451.9	152.9, 279.2, 281.2
CL 18:1_18:1_18:1_18:3	138129457	38.4	1451.9	152.9, 277.2, 281.2
CL 18:1_18:2_18:2_18:2	138291263	37.4	1449.9	152.9, 279.2, 281.2
CL 18:1_18:1_18:2_18:3/ CL 18:0_18:1_18:3_18:3	138146604/ 138304526	37.4	1449.9	152.9, 277.2, 281.2, 279.2
CL 18:2_18:2_18:2_18:2	138205444	36.7	1447.9	152.9, 279.2
CL 18:1_18:1_18:3_18:3	138164840	36.7	1447.9	152.9, 277.2, 281.2
CL 16:0_18:2_18:2_20:5/ CL 16:1_18:1_18:2_20:5	138279561/ 138138816	36.1	1445.9	152.9, 301.2, 279.2
CL 18:2_18:2_18:2_18:3	138293711	36.1	1445.9	152.9, 277.2, 279.2
CL 16:1_18:2_18:2_20:5	138173105	35.5	1443.9	152.9, 301.2, 279.2
CL 18:2_18:2_18:3_18:3/ CL 18:1_18:3_18:3_18:3	138157089/ 138184228	35.5	1443.9	152.9, 277.2, 279.2
CL 18:2_18:3_18:3_18:3	138158086	34.8	1441.9	152.9, 277.2, 279.2
CL 14:0_14:0_14:0_14:0	131797799	34.2	1239.9	152.9, 227.2
METABOLITES_END
#END